Ricevi le ultime notizie sulle azioni Galecto con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di GLTO

Ultime notizie per

Galecto

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Galecto Inc

Press Releases

Galecto Announces Reverse Stock Split

News

Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines

Management

Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler

Earnings

Galecto Reports Third Quarter 2024 Financial Results

Galecto to Participate in Upcoming Investor Conferences

Galecto Reports Full-Year 2024 Financial Results

Galecto Reports First Quarter 2025 Operating and Financial Results

Galecto Reports Second Quarter 2025 Operating and Financial Results

GLTO

Aditxt

Bone Biologics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Entero Therapeutics

ETHZilla

Genprex

GRI Bio

GT Biopharma

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Oragenics

Onconetix

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

VivoSim Labs

Longevity Health Holdings, Inc. - Common Stock

Comments

Galecto Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO